Key Metrics of Translational Development Acquisition Corp.
Revenue—FY 2023
Operating income−$486K
Net profit−$486K
Shareholders' equity−$508K
About Translational Development Acquisition Corp.
Company details
- Founded
- 2025
- Listed
- Nasdaq: TDAC (since 2025)
Company summary
Legal nameTranslational Development Acquisition Corp.
TickerTDAC
ExchangeNasdaq
CountryUnited States
SEC CIK0001926599
Listed since2025
Industry—
SectorOther Industries · Discovered Companies
Website—
US market & SEC filings
TDAC · Nasdaq · SEC CIK 0001926599
Last price · 26 Oct 2026
$10.81
+0.00%
Market cap—
P/E—On FY 2023 diluted EPS
Volume1,687
Sector—
Country · IPOUnited StatesListed 2025
TDAC share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.